# FDA Inspection 1206222 - Medtronic Neuromodulation - May 05, 2023

Source: https://www.keypedia.com/records/fda_inspections/medtronic-neuromodulation/ca41952b-debf-4e58-9a3d-a67b671f3055
Source feed: FDA_Inspections

> FDA Inspection 1206222 for Medtronic Neuromodulation on May 05, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1206222
- Company Name: Medtronic Neuromodulation
- Inspection Date: 2023-05-05
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Postmarket Assurance: Devices
- Product Type: Devices
- Office Name: Center for Devices and Radiological Health

## Related Documents

- [FDA Inspection 1206222 - 2023-05-05](https://www.keypedia.com/records/fda_inspections/medtronic-neuromodulation/0d67b0cf-c5ee-4657-8149-1b9c652318b7)
- [FDA Inspection 1187313 - 2022-11-03](https://www.keypedia.com/records/fda_inspections/medtronic-neuromodulation/0826f3ee-c543-4555-ad61-9cede8f200b3)
- [FDA Inspection 1187313 - 2022-11-03](https://www.keypedia.com/records/fda_inspections/medtronic-neuromodulation/a6f03870-6753-4fb1-ada9-63df4eba6325)
- [FDA Inspection 1153966 - 2021-09-09](https://www.keypedia.com/records/fda_inspections/medtronic-neuromodulation/67d9522f-cf08-409f-bdb3-699362a190ad)
- [FDA Inspection 1108789 - 2019-10-17](https://www.keypedia.com/records/fda_inspections/medtronic-neuromodulation/08b518e7-00db-4f3d-8411-5c55da4a26c8)

Company: https://www.keypedia.com/companies/medtronic-neuromodulation/2a0b2563-ee1c-4a97-a37a-e714223e0f65

Office: https://www.keypedia.com/offices/center-for-devices-and-radiological-health/9d89aff6-e435-4764-87be-f58c01aca7f7